Prostate dataset evaluation |
Timothy Wong |
Independent |
PLCO |
Oct 5, 2017 |
PLCO-316 |
A nested case-control study of serum levels of polyfluoroalkyl chemicals (PFCs) and renal cell carcinoma among participants in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Jonathan Hofmann |
National Cancer Institute |
PLCO |
Sep 28, 2017 |
2017-0027 |
Publicly available prostate cancer datasets |
Tim Hulsen |
Philips Research |
PLCO |
Sep 27, 2017 |
PLCO-309 |
Methodologic research for stochastic models of colorectal cancer in natural history and under screening |
Hormuzd Katki |
NCI |
PLCO |
Sep 27, 2017 |
PLCO-308 |
Identifying lethal lung cancers from non-lethal disease using CT and pathology image markers |
Peng Huang |
Johns Hopkins University |
PLCO |
Sep 20, 2017 |
2017-9001 |
Use of head and neck cancer dataset |
Monika Khurana |
Independent |
PLCO |
Sep 20, 2017 |
PLCO-306 |
Chest X-Ray Analysis Using Deep Convolutional Network |
Ashraf Khalid |
Semion Inc. |
PLCO |
Sep 8, 2017 |
PLCO-302 |
Studying neighborhood socioeconomic deprivation and colorectal cancer risk in PLCO |
Qian Xiao |
University of Iowa |
PLCO |
Sep 7, 2017 |
PLCO-303 |
Selecting the risk cut off for the LLP model. |
Kevin ten Haaf |
Erasmus MC |
PLCO |
Sep 6, 2017 |
PLCO-301 |
Detection and classification of abnormalities in Chest X-Rays |
Robert Rowley |
Flow Health, Inc. |
PLCO |
Sep 5, 2017 |
PLCO-296 |
A systematic evaluation of the relationship between reproductive factors and gynecologic outcomes in women from the PLCO: endometriosis, uterine fibroids, and endometrial and ovarian cancer. |
Ayush Giri |
Vanderbilt University Medical Center |
PLCO |
Sep 5, 2017 |
PLCO-299 |
Lifecourse body mass index trajectories and the development of endometrial and ovarian cancers |
Kara Michels |
Metabolic Epidemiology Branch |
PLCO |
Sep 5, 2017 |
PLCO-305 |
Alcohol intake and the risk of colorectal adenomas and colorectal cancer in the PLCO Cancer Screening Trial |
Kathryn Barry |
University of Maryland, Baltimore |
PLCO |
Sep 5, 2017 |
PLCO-304 |
MRI screening for lung cancer: Markov modeling using the NLST CT outcomes data |
Bradley Allen |
Northwestern University |
PLCO |
Aug 29, 2017 |
PLCO-300 |
Expanded Genome-wide Association Study of Lymphoid Malignancies and Related Disorders |
Sonja Berndt |
National Cancer Institute |
PLCO |
Aug 24, 2017 |
PLCO-298 |
The Impact of Medical Guidelines for PSA Testing on Prostate Cancer Treatment |
Armando Meier |
University of Basel |
PLCO |
Aug 16, 2017 |
PLCO-294 |
Change in smoking behaviors and BMI and their impact on the incidence and mortality of lung and colorectal cancer in the PLCO population |
Ji-Bin Li |
Sun Yat-sen University Cancer Center |
PLCO |
Aug 9, 2017 |
PLCO-295 |
Predictive methods for cancer based on machine learning |
Ashwini Suriyaprakash |
Independent |
PLCO |
Aug 8, 2017 |
PLCO-292 |
Serum levels of perfluorinated chemicals (PFCs) and aggressive prostate cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Mark Purdue |
NCI, DCEG |
PLCO |
Aug 3, 2017 |
2017-0031 |
Phase 3 validation of a serum miRNA neural network for early detection of ovarian cancer |
Kevin Elias |
Brigham and Women's Hospital |
PLCO |
Aug 3, 2017 |
2017-0023 |